Global Unit Dose Manufacturing Market 2021-2028 Analysis Report by Sourcing (Internal, Outsourcing), Product (Liquid Unit Dose, Solid Unit Dose)


DUBLIN, January 06, 2022– (BUSINESS WIRE) – “Unit Dose Manufacturing Market 2021-2028” report has been added to offer.

The global unit dose manufacturing market size is expected to reach USD 61.5 billion by 2028 and is expected to increase at a CAGR of 18.2% from 2021 to 2028.

In the first half of 2020, the market growth was stagnant, but the market started to recover at the end of 2020. This was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved. while handling and pouring doses from the same vial.

The manufacture of unit doses has many advantages because the drug can be easily identified and the formulation of the drug is protected until the time of administration. If the container is intact and the drug has not been used, it can be reused and recovered without changing its formulation. The most important advantage is that it can be administered in the appropriate dose and ensures that the patient does not exceed the prescribed limit.

However, the COVID-19 pandemic is having a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth, but by the end of 2020 the market started to recover. Unit dose manufacturing is used profitably in the current scenario as it reduces the risk of handling and contamination.

In addition, unit doses are widely used in hospitals for COVID-19 patients to protect both patients and healthcare workers to eliminate the possibility of viral transmission through airborne transmission or direct contact.

Highlights of the Unit Dose Manufacturing Market Report

  • By sourcing, the Outsourcing segment dominated the market with a revenue share of over 55.0% in 2020. This growth can be attributed to increased demand from customers and smaller pharmaceutical companies.

  • The solid unit dose products segment held the largest revenue share of over 45.0% in 2020 as it is cost effective and simple to use and has a good shelf life.

  • The independent user pharmacies segment dominated the market with a turnover share of over 30.0% in 2020. This growth can be attributed to the different products offered by this sector.

  • The United States dominates the North American market, accounting for a revenue share of over 90.0% in 2020

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

2.1 Market outlook

2.2 Segment Outlook

Chapter 3 Unit Dose Manufacturing Market: Variables, Trends and Scope

3.1 Market Lineage Outlook

3.1.1 Parents’ Market Outlook

3.1.2 Auxiliary Market Outlook

3.2 Mapping of penetration and growth prospects

3.3 Regulatory framework

3.3.1 United States

3.3.2 Canada

3.4 Market dynamics

3.4.1 Market Driver Analysis Increased adoption of unit doses Advantages of unit dose manufacturing over repackaging A flourishing pharmaceutical industry

3.4.2 Analysis of market restrictions Challenges associated with adopting manufactured unit doses

3.5 Tools for Analyzing the Unit Dose Manufacturing Market

3.5.1 Porter’s five forces analysis

3.5.2 PESTEL analysis

3.5.3 Major transactions and strategic alliances

3.5.4 Impact of COVID

Chapter 4 Unit Dose Manufacturing Market: Supply Segment Analysis

4.1 Unit Dose Manufacturing Market: Definition and Scope

4.2 Unit Dose Manufacturing: Market Share Analysis, 2020 and 2028

4.3 Internally

4.4 Outsourcing

Chapter 5 Single Dose Manufacturing Market: Product Segment Analysis

5.1 Unit Dose Manufacturing Market: Definition and Scope

5.2 Unit Dose Manufacturing: Market Share Analysis, 2020 and 2028

5.3 Manufacture of liquid unit doses

5.4 Manufacture of solid unit doses

Chapter 6 Unit Dose Manufacturing Market: End Use Segment Analysis

6.1 Unit Dose Manufacturing Market: Definition and Scope

6.2 Unit Dose Manufacturing: Market Share Analysis, 2020 and 2028

6.3 Independent pharmacies

6.4 Long-term care facility

6.5 Hospitals

Chapter 7 Unit Dose Manufacturing Market: Regional Analysis

Company Profiles

  • Catalent, Inc.

  • Patheon (Thermo Fisher Scientific Inc.)

  • Unither Pharma

  • Mikart

  • TapeMark

  • Renaissance Lakewood, LLC

  • Medical Packaging, Inc.

  • Corden Pharma

  • American health packaging

For more information on this report visit

See the source version on

Laura Wood, Senior Press Director
[email protected]
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

Source link


Comments are closed.